Sudarshan Chemical Industries Ltd Q1 FY26 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
N/A
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
N/A
0 of 0 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
See what Sudarshan Chemical Industries Ltd management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what Sudarshan Chemical Industries Ltd management said on order book — free account, 30 seconds.
Capex plans
Track Sudarshan Chemical Industries Ltd — get its next earnings analysis in your feed
Margin guidance
Order book
How does Sudarshan Chemical Industries Ltd rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does Sudarshan Chemical Industries Ltd rank in Chemicals & Petrochemicals?
Compare Sudarshan Chemical Industries Ltd against every Chemicals & Petrochemicals company (Q1 FY26) on revenue, margins and earnings-call signals.
Continue your research
What Sudarshan Chemical Industries Ltd's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q2 FY26 earnings call →
- Q1 FY26 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
Others in Chemicals & Petrochemicals this season
- Indo Borax & Ch. (Q1 FY27)
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
- SRF (Q1 FY27)
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…
- Deepak Fertilis. (Q1 FY27)
Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions. Key concall takeaways from…
- Transpek Inds. (Q1 FY27)
Planned capex of around INR 250 crores over 5-6 years, phased. Key concall takeaways from Transpek Industry Ltd's Q1 FY27 earnings call — and how it ranks…